Proyecto
 (2017)

Development of a UreI Channel Inhibitor Drug as a Complement to Conventional Helicobacter pylori Eradication Therapy

Más información

Fecha de publicación: 2017
Año de Inicio/Término: 2017-2018
Financiamiento/Sponsor: CORFO
DOI:

CORFO. 17IPPBIO-76192
Notas: Helicobacter pylori is difficult to eradicate, and 50% of the world population may be chronically infected, and given its association with cancer. A 3D UreI urea proton-coupled channel structure could provide a platform for therapeutic eradication of the bacteria and inhibitors developments.